Accendra Health (ACH) news
Recent news
Accendra Health - will not implement at-the-market issuance program
AInvest Wire · Aug 17, 2026Accendra Health - sale of two non-core assets to provide $45 mln cash injection in Q3 and Q4
AInvest Wire · Aug 17, 2026Accendra Health updates on capital allocation and CEO succession timing plans
Accendra Health, Inc. (NYSE: ACH) has outlined key updates regarding its capital allocation strategy and CEO succession plans. The company recently authorized a $100 million share repurchase program, under which it repurchased approximately 2.0 million shares for $10 million as of December 31,…
AInvest Wire · Aug 17, 2026Accendra Health Inc: Citigroup cuts to neutral from buy; cuts target price to $1.5 from $4.5
AInvest Wire · Aug 11, 2026Accendra Health Inc: Baird cuts to neutral rating; cuts target price to $1.5 from $6
Baird analyst David Drzal downgraded Accendra Health Inc. (ACH) to a Neutral rating from Outperform and reduced the stock price target to $1.50 from $6, citing ongoing operational and financial challenges. This move follows recent earnings reports that highlighted a difficult operating environment,…
AInvest Wire · Aug 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.